ReviewNature immunology2026
Multimerizing transcription factors FOXP3 and AIRE as chromatin architectural regulators.
Review in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Central and peripheral immune tolerance depend on distinct transcriptional programs orchestrated by autoimmune regulator (AIRE) and FOXP3, respectively. AIRE promotes the expression of peripheral tissue antigens in medullary thymic epithelial cells for negative selection of autoreactive T cells, whereas FOXP3 enforces the immune-suppressive program of regulatory T cells. Although their immunological roles are well established, the molecular mechanisms by which AIRE and FOXP3 engage the genome and regulate transcription have long been unclear. Recent structural, biochemical and genomic work has revealed an unexpected shared principle: both FOXP3 and AIRE form homomultimers that function as chromatin organizers. Despite functioning in different immunological contexts and possessing distinct modes of genome interaction, both proteins leverage and reinforce pre-existing chromatin landscapes to coordinate broader gene expression programs. In this Review, we summarize recent advances and emerging mechanistic insights into FOXP3 and AIRE, focusing on their multimerization, interactions with repetitive DNA and enhancers and roles as architectural regulators that shape transcriptional programs essential for immune tolerance.
Indexed as
Identifiers
41933202What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.